AMED
Amedisys
AMED
AMED
Delisted
AMED was delisted on the 14th of August, 2025.
298 hedge funds and large institutions have $2.67B invested in Amedisys in 2025 Q1 according to their latest regulatory filings, with 53 funds opening new positions, 110 increasing their positions, 81 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
298
Holders Change
+13
Holders Change %
+4.56%
% of All Funds
4.05%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.14%
New
53
Increased
110
Reduced
81
Closed
36
Calls
$6.96M
Puts
$205M
Net Calls
-$198M
Net Calls Change
+$89.8M
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$48.1M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$39.1M |
| 3 |
Millennium Management
New York
|
+$20.4M |
| 4 |
SAMU
SONA Asset Management (US)
New York
|
+$19.1M |
| 5 |
SGCM
Sand Grove Capital Management
London,
United Kingdom
|
+$18.1M |
Top Sellers
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$50.7M |
| 2 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
-$39.8M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$37.7M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$34.4M |
| 5 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$28.5M |
